Tejnaksh Healthcare Ltd (BSE: 539428) is a Dhule, Maharashtra-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹27 Cr, it ranks #4,361 by market cap among the 6,137 Indian listed companies on FinBizNet, and #37 of 42 in Hospitals and Healthcare Centers. At ₹11.78 (as of 25 Oct 2026), the share price is 36.7% below its 52-week high of ₹18.60 and 10.6% above its 52-week low of ₹10.65. The share price is down 32.4% over one year and down 17.3% over three months.
| Current Price | ₹11.78 |
|---|---|
| Market Cap | ₹27 Cr |
| BSE Code | 539428 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 21.5 |
| Return on Equity | 4.37% |
| Return on Assets | 3.17% |
| 52-Week Range | ₹10.65 – ₹18.60 |
| 1-Year Price Change | -32.4% |
| 3-Month Price Change | -17.3% |
| Beta (1Y) | 0.33 |
| Headquarters | Dhule, Maharashtra |
| Website | tejnaksh.com |
Tejnaksh Healthcare Limited provides hospital and healthcare services in India. The company offers health care services through urology clinics, urology hospitals, and dental super specialty clinics; and operates multi-specialty hospitals, super-specialty hospitals, education institutes, pathology labs, super specialty training institutes, simulation institutes, and stone analysis labs. It also sells healthcare equipment, medical goods, and pharmaceuticals. In addition, the company is involved in the provision of inpatient and outpatient services. Tejnaksh Healthcare Limited was founded in 2003 and is headquartered in Dhule, India.
1. Medical and Healthcare Services-This segment offers healthcare services at urology clinics, urology hospitals, and dental super specialty clinics.
1. Medical and Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,13,446 Cr | 57 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹84,500 Cr | 82.1 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹82,242 Cr | 56.3 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,702 Cr | 88.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹55,603 Cr | 53.3 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹33,340 Cr | 60 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹27,434 Cr | 112.5 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹14,767 Cr | 112 | 8.31% | ₹614 Cr | -9.3% |
| Tejnaksh Healthcare Ltd | ₹27 Cr | 21.5 | 4.37% | — | -32.4% |
Listed by market capitalisation. Ratios are shown for context only.
Tejnaksh Healthcare Ltd is trading at ₹11.78, with a market capitalisation of ₹27 Cr.
Tejnaksh Healthcare Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Tejnaksh Healthcare Ltd has a P/E of 21.5 and a return on equity of 4.37%.
Tejnaksh Healthcare Ltd is listed on the BSE under the scrip code 539428.
Tejnaksh Healthcare Ltd's share price is down 32.4% over one year and down 17.3% over three months. Its 52-week range is ₹10.65 to ₹18.60.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.